Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Biological Mimetics Logo
Biological Mimetics CB Rank
689515
Heat Score
60
Biological Mimetics engages in the research and development of new generation antigens, vaccines, & antibodies.
Founded
obfuscation
Private Frederick, Maryland, United States1-10 biologicalmimetics.com/
Biotechnology
Health Care
Product Research
Overview

Biological Mimetics
Heat Score
60

Growth Score
pts
in past quarter
Heat Score 60
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Biological Mimetics

CB Rank
689515
Biological Mimetics engages in the research and development of new generation antigens, vaccines, & antibodies.
Founded
obfuscation
Private Frederick, Maryland, United States1-10 biologicalmimetics.com/
Biotechnology
Health Care
Product Research

Key People

  • Photo of Peter Nara
    Peter Nara: Chairman Emeritus
    Past Role: Lantern Pharma, Former Consultant
  • Photo of Peter Nara
    Peter Nara: President and CEO
    Past Role: Lantern Pharma, Former Consultant

Details

Also Known As BMI
Operating Status Active
Company Type For Profit
Phone Number 301-378-2551
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Immune Refocusing Technology (IRT)
A platform that identifies and dampens immunodominant divergent epitopes to focus immune responses on conserved antigenic sites.
Ultra IPV Vaccine Platform
A vaccine development platform using UVC irradiation combined with manganese-decapeptide-phosphate (MDP) to inactivate pathogens for vaccine production.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 4

Employee Profiles

News
Technology
View Tech Report

IT Spend

$32.4KThis year, Biological Mimetics is projected to spend $32.4K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Cloud Repository Logo
Cloud Repository
80

Actively Used Products

7Biological Mimetics uses 7 technology products and services including HTML5, Apache Server, and  Vimeo, according to G2 Stack.

Active Website Tech Count

3Biological Mimetics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.

Total IP

17The intellectual property of Biological Mimetics includes 15 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Biological Mimetics has registered 2 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Biological Mimetics's headquarters? Biological Mimetics is located in Frederick, Maryland, United States.Who are Biological Mimetics's competitors? Alternatives and possible competitors to Biological Mimetics may include International AIDS Vaccine Initiative, Valneva, and  etherna immunotherapies.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|